US › Healthcare

Sunshine Biopharma Inc (SBFM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.84-18.35%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$9.3M

Revenue YoY

-1.6%

Net profit

$-1.6M

EPS

$-1.15

EPS estimate

$-1.20

Net margin

-16.9%

EPS came in at -1.15 against a street estimate of -1.20 — a beat of 4.2%.

Key statistics

Market cap

$4.1M

Forward P/E

0.0

P/B

0.15

Book value

$11.52

EPS (TTM)

$-9.16

52-week high

$24.30

52-week low

$1.01

50-day MA

$1.43

200-day MA

$7.74

Beta

1.32

Analyst view

Analysts rate Sunshine Biopharma Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $56.00.

Shareholding

Insiders

1.77%

Institutions

7.13%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.19%
TWO SIGMA SECURITIES, LLC	0.10%
XTX Topco Ltd	0.09%
Morgan Stanley - Brokerage Accounts	0.06%
SBI Securities Co Ltd	0.01%
UBS Group AG	0.00%
NATIONAL BANK OF CANADA /FI/	0.00%
Advisor Group Holdings, Inc.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sunshine Biopharma Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.